Brainstorm Cell Therapeutics Inc Says on July 18, Co Received Mvls Deficiency Notice From the Listing Qualifications Department Staff of Nasdaq
Brainstorm cell therapeutics公司於7月18日收到納斯達克上市資格部門工作人員發來的MVLS違規通知。
Brainstorm Cell Therapeutics Inc Says on July 18, Co Received Mvls Deficiency Notice From the Listing Qualifications Department Staff of Nasdaq
Brainstorm cell therapeutics公司於7月18日收到納斯達克上市資格部門工作人員發來的MVLS違規通知。
譯文內容由第三人軟體翻譯。